This company has shut down. Visus Therapeutics is no longer operating — its last tracked round was a Debt Financing in 2021.
Explore the Startup GraveyardVisus Therapeutics is a clinical-stage company developing innovative medicines.
Visus Therapeutics has raised $20.0M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2021.
Visus Therapeutics's investors include RTW Investments, EQT Life Sciences, Johnson & Johnson Innovation, Wille Finance.
Visus Therapeutics is headquartered in Seattle, United States.
Visus Therapeutics is a clinical-stage company developing innovative medicines.
Visus Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Visus Therapeutics — Funding & Investors." VCBacked, August 10, 2021, https://www.vcbacked.co/company/visus-therapeutics. Accessed August 15, 2026.
VCBacked. (2021). Visus Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/visus-therapeutics
{{cite web |title=Visus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/visus-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated